pharmaceutical


Also found in: Dictionary, Thesaurus, Encyclopedia, Wikipedia.

pharmaceutical

 [fahr″mah-soo´tĭ-k'l]
1. pertaining to pharmacy or drugs.
2. a medicinal drug.

phar·ma·ceu·tic

, pharmaceutical (far'mă-sū'tik, sū'ti-kăl),
Relating to pharmacy or to pharmaceutics.
Synonym(s): pharmacal
[G. pharmakeutikos, relating to drugs]

pharmaceutical

/phar·ma·ceu·ti·cal/ (-soo´tĭ-k'l)
1. pertaining to pharmacy or drugs.
2. a medicinal drug.

pharmaceutical

(fär′mə-so͞o′tĭ-kəl) also

pharmaceutic

(-tĭk)
adj.
Of or relating to pharmacy or pharmacists.
n.
A pharmaceutical product or preparation.

phar′ma·ceu′ti·cal·ly adv.

phar·ma·ceu·tic

, pharmaceutical (fahrmă-sūtik, -ăl)
Relating to pharmacy or to pharmaceutics.
[G. pharmakeutikos, relating to drugs]

pharmaceutical

1. Any DRUG intended for medicinal use.
2. Pertaining to medicinal drugs or to the preparation and use of drugs (pharmaceutics).

Pharmaceutical

Pertaining to drugs.

phar·ma·ceu·tic

, pharmaceutical (fahrmă-sūtik, -ăl)
Relating to pharmacy or pharmaceutics.
[G. pharmakeutikos, relating to drugs]

pharmaceutical

1. pertaining to pharmacy or drugs.
2. a medicinal drug.

pharmaceutical incompatibility
substances that react chemically with each other, e.g. acids and alkalis, and cannot both be included in the same formulation.
pharmaceutical industry
the manufacturers of pharmaceuticals. Also one of the biggest research contributors to human and veterinary medicine. This includes basic research into chemotherapy but includes also the otherwise neglected fields of formulations, packaging, dosing regimens and dispensing information. The industry also has access to the biggest database relating to chemicals and their uses.
References in periodicals archive ?
If this round of testing indicates that the PEC of the drug will be greater than the PNEC, then pharmaceutical companies following the European approach must propose recommendations to limit the drug's impact on the environment.
Mullen noted that two pharmaceutical engineering and construction industry veterans with more than 50 years of combined experience in facilities validation for FDA approval have joined the company to support the new group.
Overview of macro-environmental and regulatory issues affecting the Chinese pharmaceutical industry
Factors that may cause such differences include, but are not limited to, changes in third party reimbursement and government mandates which impact pharmaceutical pricing, competition from other manufacturers of generic and proprietary pharmaceuticals, risks associated with the timing and nature of regulatory approvals, and other uncertainties detailed in Bentley's most recent Annual Report on Form 10-K and its other subsequent periodic reports filed with the Securities and Exchange Commission.
Most recently, Solvay Pharmaceuticals submitted a New Drug Application (NDA) in April 2006 to the FDA for fluvoxamine maleate extended-release capsules, an investigational compound being studied for the treatment of generalized social anxiety disorder (SAD) and obsessive compulsive disorder (OCD) in adults.
Organization and funding of the German health care system: spending, pharmaceutical prices relative to other major markets, statutory health insurance, and regular health care reforms.
In the next 12 to 24 months, China Health plans to complete further acquisitions and transactions with major pharmaceutical companies in the People's Republic of China, bringing its total assets to approximately US$100 million.
5 thousand pharmaceutical wholesale enterprises nationwide.
was formed as a separate specialty pharmaceutical company for the research, development, manufacturing, licensing and acquisition of specialty generic pharmaceuticals.
Margins across the pharmaceutical distribution channel are anticipated to hold relatively steady aided by operating cost efficiencies for brand-name drug manufacturers, and increased generic drug utilization for generic drug manufacturers, distributors and PBMs.
In addition to the pending Xi'an Chunhui Pharmaceuticals, China Health has announced several other pending or completed acquisitions of China-based pharmaceutical firms in recent months.

Full browser ?